Valantine, Hannah.
Hannah Valantine Professor of Cardiovascular Medicine
VIAF ID: 316644157 (Personal)
Permalink: http://viaf.org/viaf/316644157
Preferred Forms
-
100 0 _
‡a
Hannah Valantine
‡c
Professor of Cardiovascular Medicine
-
100 1 _
‡a
Valantine, Hannah
-
100 1 _
‡a
Valantine, Hannah
-
100 1 _ ‡a Valantine, Hannah
-
100 1 _ ‡a Valantine, Hannah.
4xx's: Alternate Name Forms (8)
Works
| Title | Sources |
|---|---|
| Academic couples: implications for medical school faculty recruitment and retention |
|
| Changing the culture of academic medicine to eliminate the gender leadership gap: 50/50 by 2020 |
|
| Changing trends in infectious disease in heart transplantation. |
|
| Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy. |
|
| Decisions, Decisions: How Program Diversity Influences Residency Program Choice |
|
| Designing a physician leadership development program based on effective models of physician education |
|
| From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation |
|
| Giant Coronary Aneurysms in Heart Transplantation: an Unusual Presentation of Cardiac Allograft Vasculopathy |
|
| Guidelines for the treatment and management of new-onset diabetes after transplantation |
|
| Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection |
|
| Inclusive excellence in biomedical research, 2021: |
|
| Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab. |
|
| An Integrated Career Coaching and Time Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine |
|
| Karl Maughan |
|
| Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience |
|
| Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. |
|
| Noninvasive monitoring of infection and rejection after lung transplantation |
|
| Policy: NIH push to stop sexual harassment |
|
| Precision medicine in action, 2015: |
|
| Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. |
|
| Proceedings of a symposium on individualizing immunosuppression : strategies for the next decade, October 25-26, 1996, Tucson, Arizona |
|
| Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature |
|
| Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype |
|
| Reducing Implicit Gender Leadership Bias in Academic Medicine With an Educational Intervention |
|
| Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection |
|
| Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. |
|
| Towards Equity in Health: Researchers Take Stock |
|
| Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation |
|
| Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty |
|
